StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
January 27, 2025 11:46 AM
Mizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
HCA Healthcare Inc (HCA) PT Lowered to $377 at TD Cowen
January 27, 2025 10:11 AM
HCA Healthcare Inc (HCA) PT Lowered to $384 at RBC Capital on Likely Policy Overhang
January 27, 2025 9:02 AM
Cantor Fitzgerald Reiterates Overweight Rating on HCA Healthcare Inc (HCA)
January 27, 2025 7:35 AM
HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners
January 27, 2025 6:23 AM
KeyBanc Reiterates Overweight Rating on HCA Healthcare Inc (HCA) After a 'Good Quarter'
January 27, 2025 6:00 AM
Hamilton ETFs Announces January 2025 Cash Distributions
January 24, 2025 5:00 PM
HCA Healthcare forecasts upbeat 2025 profit on strong medical care demand
January 24, 2025 8:09 AM
Form 8-K HCA Healthcare, Inc. For: Jan 24
January 24, 2025 7:41 AM
HCA Holdings (HCA) Tops Q4 EPS by 8c, Offers Guidance, Approves $10B Buyback
January 24, 2025 7:34 AM
HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance
January 24, 2025 7:30 AM
